We are live on ! Find out more
VPHM

VIROPHARMA INC
VPHM

Delisted

VPHM was delisted on the 23rd of January, 2014.

Back to rankings

191 hedge funds and large institutions have $2.87B invested in VIROPHARMA INC in 2013 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 63 increasing their positions, 69 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 19

45% more capital invested

Capital invested by funds: $1.98B → $2.87B (+$896M)

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

10% more funds holding

Funds holding: 174 → 191 (+17)

6% less call options, than puts

Call options by funds: $72.1M | Put options by funds: $76.7M

9% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 69

Holders
191
Holders Change
+17
Holders Change %
+9.77%
% of All Funds
6.19%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.13%
New
39
Increased
63
Reduced
69
Closed
19
Calls
$72.1M
Puts
$76.7M
Net Calls
-$4.64M
Net Calls Change
-$4.43M

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$137M
2
PI
Putnam Investments
Massachusetts
+$119M
3
PC
PointState Capital
New York
+$43.1M
4
MC
Maverick Capital
Texas
+$40.9M
5
PCM
Pentwater Capital Management
Florida
+$40.9M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$96M
2
SCM
Scopia Capital Management
New York
-$39.8M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$33.3M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$31.5M
5
PAI
Palo Alto Investors
California
-$28.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity International
101
Fidelity International
Bermuda
$1.94M -$2.35M -71,780 -59%
VAM
102
Visium Asset Management
New York
$1.85M +$1.54M +47,100 New
SO
103
STRS Ohio
Ohio
$1.82M -$232K -7,100 -13%
VOYA Investment Management
104
VOYA Investment Management
Georgia
$1.73M – – –
NTCOC
105
Northern Trust Company of Connecticut
Connecticut
$1.7M -$105K -3,220 -7%
CAM
106
Capstone Asset Management
Texas
$1.58M +$27.8K +850 +2%
CA
107
Commerzbank Aktiengesellschaft
Germany
$1.48M +$1.23M +37,627 New
DekaBank Deutsche Girozentrale
108
DekaBank Deutsche Girozentrale
Germany
$1.43M +$1.19M +36,500 New
DILH
109
Dai-ichi Life Holdings
Japan
$1.36M +$1.13M +34,616 New
ERSOT
110
Employees Retirement System of Texas
Texas
$1.34M -$3.53M -108,000 -76%
LOM
111
Loeb Offshore Management
New York
$1.19M +$994K +30,400 New
EIM
112
Essex Investment Management
Massachusetts
$1.15M -$254K -7,755 -21%
HT
113
HAP Trading
New York
$1.14M +$945K +28,899 New
MF
114
Magnetar Financial
Illinois
$1.06M +$886K +27,083 New
TS
115
Twin Securities
New York
$1.04M +$866K +26,500 New
JG
116
Jefferies Group
New York
$1.01M +$825K +25,226 +4,473%
ACM
117
Advent Capital Management
New York
$981K +$817K +25,000 New
TRSOTSOK
118
Teachers Retirement System of the State of Kentucky
Kentucky
$974K -$62.1K -1,900 -7%
Thrivent Financial for Lutherans
119
Thrivent Financial for Lutherans
Minnesota
$938K – – –
HM
120
Harvest Management
New York
$903K +$752K +23,000 New
TC
121
TFS Capital
Pennsylvania
$901K +$751K +22,962 New
GCP
122
GSA Capital Partners
United Kingdom
$884K +$736K +22,499 New
Group One Trading
123
Group One Trading
Illinois
$838K +$694K +21,213 +15,045%
GH
124
GAM Holding
Switzerland
$814K – – –
PA
125
Profund Advisors
Maryland
$774K +$96.2K +2,942 +18%
3 4
5
6 7

VPHM Hedge Fund Activity: Q3 2013 in Review

191 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in VIROPHARMA INC (VPHM) for Q3 2013, worth a combined $2.87B — up 45% from $1.98B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new VPHM positions and 19 closed out — a net gain of 20 holders — while 63 added to existing stakes and 69 trimmed.

The largest buyer was Westfield Capital Management, adding an estimated $137M. The largest seller was Baker Bros. Advisors, cutting an estimated $96M.

  • 191 institutional investors held VIROPHARMA INC (VPHM) as of Q3 2013, up from 174 in Q2 2013.
  • Funds reported $2.87B of VIROPHARMA INC stock for Q3 2013, up 45% quarter-over-quarter.
  • 39 funds opened new VIROPHARMA INC positions in Q3 2013 and 19 closed out, a net change of +20 holders.
  • The largest VIROPHARMA INC buyer in Q3 2013 was Westfield Capital Management, an estimated $137M added.
  • The largest VIROPHARMA INC seller in Q3 2013 was Baker Bros. Advisors, an estimated $96M sold.

Based on aggregated 13F filings for Q3 2013.